{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:24:31Z","timestamp":1774992271544,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecules and Cells"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.14348\/molcells.2016.0023","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T03:47:34Z","timestamp":1483415254000},"page":"869-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia"],"prefix":"10.1016","volume":"39","author":[{"given":"Xiaoyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14348\/molcells.2016.0023_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"10.14348\/molcells.2016.0023_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm0804-786","article-title":"Treating cancer\u2019s kinase \u2018addiction\u2019","volume":"10","author":"Baselga","year":"2004","journal-title":"Nat. Med."},{"key":"10.14348\/molcells.2016.0023_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia","volume":"25","author":"Bixby","year":"2010","journal-title":"Leukemia"},{"key":"10.14348\/molcells.2016.0023_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/carcin\/bgs345","article-title":"Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage","volume":"34","author":"Blakemore","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.14348\/molcells.2016.0023_bib5","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1158\/1535-7163.MCT-06-0273","article-title":"Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2A alpha","volume":"5","author":"Bonness","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.14348\/molcells.2016.0023_bib6","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.18632\/oncotarget.2361","article-title":"Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr\/Abl-dependent and - independent mechanisms","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"key":"10.14348\/molcells.2016.0023_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/MCB.22.3.874-885.2002","article-title":"Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases","volume":"22","author":"Crosio","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.14348\/molcells.2016.0023_bib8","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/sj.onc.1203484","article-title":"JAK-STAT signaling activated by Abl oncogenes","volume":"19","author":"Danial","year":"2000","journal-title":"Oncogene"},{"key":"10.14348\/molcells.2016.0023_bib9","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.14348\/molcells.2016.0023_bib10","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.14348\/molcells.2016.0023_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(91)90583-K","article-title":"cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2","volume":"67","author":"Gautier","year":"1991","journal-title":"Cell"},{"key":"10.14348\/molcells.2016.0023_bib12","doi-asserted-by":"crossref","first-page":"18469","DOI":"10.18632\/oncotarget.4063","article-title":"PP2A inhibitors arrest G2\/M transition through JNK\/Sp1-dependent downregulation of CDK1 and autophagy-dependent up-regulation of p21","volume":"6","author":"Gong","year":"2015","journal-title":"Oncotarget"},{"key":"10.14348\/molcells.2016.0023_bib13","doi-asserted-by":"crossref","first-page":"39223","DOI":"10.1074\/jbc.M007291200","article-title":"BCR\/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3- Kinase\/AKT pathway","volume":"275","author":"Gesbert","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.14348\/molcells.2016.0023_bib14","first-page":"2187","article-title":"Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin","volume":"8","author":"Han","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.14348\/molcells.2016.0023_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.14348\/molcells.2016.0023_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3892\/ijo.2014.2428","article-title":"Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways","volume":"45","author":"Hsia","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.14348\/molcells.2016.0023_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/tox.21986","article-title":"Cantharidin induces DNA damage and inhibits DNA repair-associated protein levels in NCI-H460 human lung cancer cells","volume":"30","author":"Hsia","year":"2015","journal-title":"Environ. Toxicol."},{"key":"10.14348\/molcells.2016.0023_bib18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/ijo.2014.2689","article-title":"Cantharidin induces G2\/M phase arrest by inhibition of Cdc25c and Cyclin A and triggers apoptosis through reactive oxygen species and the mitochondria- dependent pathways of A375.S2 human melanoma cells","volume":"45","author":"Hsiao","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.14348\/molcells.2016.0023_bib19","first-page":"1067","article-title":"Cantharidin induces G2\/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways","volume":"38","author":"Huang","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.14348\/molcells.2016.0023_bib20","first-page":"190","article-title":"Suppressions of migration and invasion by cantharidin in TSGH- 8301 human bladder carcinoma cells through the inhibitions of matrix metalloproteinase-2\/-9 signaling","volume":"2013","author":"Huang","year":"2013","journal-title":"Evid. Based Complement Alternat. Med. eCAM"},{"key":"10.14348\/molcells.2016.0023_bib21","first-page":"1243","article-title":"Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria- dependent signal pathways","volume":"37","author":"Kuo","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.14348\/molcells.2016.0023_bib22","first-page":"795","article-title":"Cantharidin induces DNA damage and inhibits DNA repair-associated protein expressions in TSGH8301 human bladder cancer cell","volume":"35","author":"Kuo","year":"2015","journal-title":"Anticancer Res."},{"key":"10.14348\/molcells.2016.0023_bib23","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.ejca.2011.08.014","article-title":"Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through over activation of the c-Jun N- terminal kinase pathway","volume":"47","author":"Li","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.14348\/molcells.2016.0023_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2011.02.009","article-title":"PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKa and sustained activation of the NF-KB pathway","volume":"304","author":"Li","year":"2011","journal-title":"Cancer Lett."},{"key":"10.14348\/molcells.2016.0023_bib25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","article-title":"Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"key":"10.14348\/molcells.2016.0023_bib26","article-title":"Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo.","volume":"2016","author":"Li","year":"2016","journal-title":"Environ. Toxicol."},{"key":"10.14348\/molcells.2016.0023_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","article-title":"Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"290","author":"Lu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.14348\/molcells.2016.0023_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.14348\/molcells.2016.0023_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ccr.2005.10.015","article-title":"The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL- regulated SET protein","volume":"8","author":"Neviani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.14348\/molcells.2016.0023_bib30","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/j.1460-2075.1991.tb04896.x","article-title":"Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates","volume":"10","author":"Norbury","year":"1991","journal-title":"EMBO J."},{"key":"10.14348\/molcells.2016.0023_bib31","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood."},{"key":"10.14348\/molcells.2016.0023_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2005.02.007","article-title":"New insights into cyclins, CDKs, and cell cycle control","volume":"16","author":"Sanchez","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.14348\/molcells.2016.0023_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1078-0432.CCR-13-1063","article-title":"Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.14348\/molcells.2016.0023_bib34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/or.2013.2601","article-title":"Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of a2 integrin","volume":"30","author":"Shou","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.14348\/molcells.2016.0023_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1142\/S0192415X15500366","article-title":"Cantharidin induces apoptosis through the Calcium\/PKC-regulated endoplasmic reticulum stress pathway in human bladder cancer cells.","volume":"43","author":"Su","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.14348\/molcells.2016.0023_bib36","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3892\/or.2015.3942","article-title":"Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2\/Bax","volume":"33","author":"Tian","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.14348\/molcells.2016.0023_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-8741(89)90062-7","article-title":"Medical uses of mylabris in ancient China and recent studies","volume":"26","author":"Wang","year":"1989","journal-title":"J. Ethnopharmacol."},{"key":"10.14348\/molcells.2016.0023_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1158\/1541-7786.MCR-05-0172","article-title":"Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl- expressing cells","volume":"4","author":"Wolanin","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.14348\/molcells.2016.0023_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3892\/or.2014.3266","article-title":"PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt\/p-catenin pathway by phosphorylation and degradation of p-catenin","volume":"32","author":"Wu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.14348\/molcells.2016.0023_bib40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/mc.20553","article-title":"Diallyl trisulfide-induced apoptosis in human cancer cells is linked to checkpoint kinase 1- mediated mitotic arrest","volume":"48","author":"Xiao","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.14348\/molcells.2016.0023_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1142\/S0192415X14500360","article-title":"Effect of cantharidins in chemotherapy for hepatoma: a retrospective cohort study","volume":"42","author":"Zhang","year":"2014","journal-title":"Am. J. Chin. Med."}],"container-title":["Molecules and Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823051142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823051142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ocean.kisti.re.kr\/downfile\/crosscheck\/ksmcb\/JAKO201606776009999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:52:58Z","timestamp":1760896378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1016847823051142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1016847823051142"],"URL":"https:\/\/doi.org\/10.14348\/molcells.2016.0023","relation":{},"ISSN":["1016-8478"],"issn-type":[{"value":"1016-8478","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Molecules and Cells","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14348\/molcells.2016.0023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 THE AUTHORS. Published by Elsevier Inc on behalf of the Korean Society for Molecular and Cellular Biology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}